Advertisement

The Latest

A health insurance firm in Germantown, Wis., and its parent company have agreed to pay $4.8 million to settle whistleblower claims of healthcare fraud, according to a Milwaukee Journal Sentinel report. Abri Health Plan and its parent company, Universal American…

The FDA has approved Remicade from Janssen Biotech to treat moderately to severely active ulcerative colitis in children over age 6 who responded inadequately to conventional therapy, according to an FDA news release.

Researchers at the University of Michigan, University of California-San Francisco and the Atlanta Pediatric Device Consortium have won a total of $5 million in FDA grants to develop pediatric devices for rare diseases and conditions, according to an FDA news…

Advertisement